title: Late presentation to HIV/AIDS testing, treatment or continued care: clarifying the use of CD4 evaluation in the consensus definition.
abstract: OBJECTIVE
  Late presentation to HIV/AIDS services compromises treatment outcomes and misses opportunities for biomedical and behavioural prevention. There has been significant heterogeneity in how the term 'late presentation' (LP) has been used in the literature. In 2011, a consensus definition was reached using CD4 counts to define and measure late presenters and, while it is useful for clinical care, the consensus definition has several important limitations that we discuss in this article.
  
  
  METHODS
  Using the spectrum of engagement in HIV care presented by Gardner and colleagues, this article highlights issues and opportunities associated with use of the consensus definition.
  
  
  RESULTS
  The consensus definition is limited by three principal factors: (1) the CD4 count threshold of 350 cells/μL is being increasingly questioned as the biomedical justification grows for earlier initiation of treatment; (2) CD4 evaluations are conducted at multiple services providing HIV care; thus it remains unclear to which service the patient is presenting late; and (3) the limited availability of CD4 evaluation restricts its use in determining the prevalence of LP in many settings.
  
  
  CONCLUSIONS
  The consensus definition is useful because it describes the level of disease progression and allows for consistent evaluation of the prevalence and determinants of LP. Suggestions are provided for improving the application of the consensus definition in future research.
authors.affiliation: Alpert Medical School of Brown University and The Miriam Hospital, Providence, RI, USA.
authors.forename: S
authors.initials: S
authors.lastname: MacCarthy
authors.forename: D R
authors.initials: DR
authors.lastname: Bangsberg
authors.forename: G
authors.initials: G
authors.lastname: Fink
authors.forename: M
authors.initials: M
authors.lastname: Reich
authors.forename: S
authors.initials: S
authors.lastname: Gruskin
mesh_terms: D018791:CD4 Lymphocyte Count; D015496:CD4-Positive T-Lymphocytes / Q000378:metabolism*; D057210:Delayed Diagnosis; D018450:Disease Progression; D015658:HIV Infections / Q000175:diagnosis* / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D013997:Time Factors
keywords: CD4 evaluations; HIV/AIDS; late presentation; testing; treatment
references.citation: AIDS Care. 2007 Feb;19(2):195-202
references.pmid: 17364398
references.citation: Nat Med. 2002 May;8(5):522-6
references.pmid: 11984599
references.citation: AIDS Patient Care STDS. 2006 Dec;20(12):838-47
references.pmid: 17192149
references.citation: BMJ. 2007 Jun 30;334(7608):1354-6
references.pmid: 17600025
references.citation: AIDS. 2011 Nov 28;25(18):2259-68
references.pmid: 21918422
references.citation: AIDS Care. 2010 Jun;22(6):766-74
references.pmid: 20467939
references.citation: J Am Soc Nephrol. 2005 Aug;16(8):2412-20
references.pmid: 15987747
references.citation: Int J STD AIDS. 2000 Aug;11(8):503-8
references.pmid: 10990334
references.citation: PLoS One. 2009;4(2):e4445
references.pmid: 19214229
references.citation: N Engl J Med. 2011 Aug 11;365(6):493-505
references.pmid: 21767103
references.citation: Antivir Ther. 2010;15 Suppl 1:3-8
references.pmid: 20442455
references.citation: Clin Infect Dis. 2010 Jun 1;50(11):1512-20
references.pmid: 20415573
references.citation: Cad Saude Publica. 2006 Apr;22(4):751-60
references.pmid: 16612429
references.citation: HIV Med. 2012 Sep;13 Suppl 2:1-85
references.pmid: 22830364
references.citation: PLoS One. 2012;7(9):e45692
references.pmid: 23029184
references.citation: AIDS. 2012 Sep 10;26(14):1735-8
references.pmid: 22614888
references.citation: BMC Public Health. 2010 Jul 13;10:416
references.pmid: 20626905
references.citation: J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):397-405
references.pmid: 19550350
references.citation: N Engl J Med. 2013 Jan 17;368(3):207-17
references.pmid: 23323897
references.citation: Nephrol Dial Transplant. 2006 Oct;21(10):2809-13
references.pmid: 16864598
references.citation: Clin Infect Dis. 2006 Aug 1;43(3):377-80
references.pmid: 16804855
references.citation: AIDS Res Ther. 2011 Feb 28;8:8
references.pmid: 21356115
references.citation: AIDS Res Ther. 2008 Apr 16;5:6
references.pmid: 18416849
references.citation: AIDS. 2006 Nov 28;20(18):2371-9
references.pmid: 17117024
references.citation: J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):280-9
references.pmid: 19521248
references.citation: Clin Infect Dis. 2011 Nov;53(9):927-35
references.pmid: 21890751
references.citation: Clin Infect Dis. 2011 Dec;53(11):1043-50
references.pmid: 22021928
references.citation: N Engl J Med. 2013 Jan 17;368(3):218-30
references.pmid: 23323898
references.citation: J Acquir Immune Defic Syndr. 2012 Jan 1;59(1):86-93
references.pmid: 21937921
references.citation: Clin Infect Dis. 2011 Mar 15;52(6):793-800
references.pmid: 21367734
references.citation: Curr HIV Res. 2009 Mar;7(2):224-30
references.pmid: 19275591
references.citation: AIDS. 2008 Feb 19;22(4):481-7
references.pmid: 18301060
references.citation: Am J Public Health. 2001 Jul;91(7):1019-24
references.pmid: 11441723
references.citation: J Acquir Immune Defic Syndr. 2012 Jul 1;60(3):e90-7
references.pmid: 22421747
references.citation: Int J STD AIDS. 2010 Dec;21(12):802-5
references.pmid: 21297086
references.citation: HIV Med. 2011 Jan;12(1):61-4
references.pmid: 20561080